Fiorella Krapp
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Fiorella Krapp has a total of 183 co-authors. Here are the top co-authors by number of shared publications:
- Coralith García
Instituto de Medicina Tropical Alexander von Humboldt, Universidad Peruana Cayetano Heredia
6 shared publications - Carlos Seas
Universidad Peruana Cayetano Heredia
5 shared publications - Carlos Zamudio
Universidad Peruana Cayetano Heredia, Lima, Peru
5 shared publications - Jan Jacobs
Department of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium. Department of Microbiology, Immunology and Transplantation, KU Leuven, Leuven, Belgium
5 shared publications - Noemí Hinostroza
Instituto de Medicina Tropical Alexander von Humboldt, Universidad Peruana Cayetano Heredia. Lima, Perú
5 shared publications Eduardo Gotuzzo
Instituto de Medicina Tropical Alexander von Humboldt, Universidad Peruana Cayetano Heredia, Lima, Peru; Departamento de Enfermedades Infecciosas, Tropicales y Dermatologicas, Hospital Nacional Cayetano Heredia, Lima, Peru
4 shared publications
Latest Publications
- Open Access
- 1 September 2026
- Published by American Society for Microbiology in Microbiology Spectrum
- Vol. 14 (9)
In vitro susceptibility testing of aztreonam-avibactam against predominantly NDM-producing Enterobacterales in Peru
Metallo-β-lactamase-producing Enterobacterales are distributed worldwide, but some Latin American countries show a higher prevalence. Aztreonam-avibactam (ATM-AVI) may be an option for treating these infections. To evaluate in vitro susceptibility to aztreonam (ATM) alone and ATM-AVI in carbapenem-non-susceptible Enterobacterales isolates, based on the type of carbapenemase production, we prospectively collected carbapenem-non-susceptible Enterobacterales isolates from Peruvian hospitals during 2023–2024. Identification and susceptibility testing were performed by commercial panels and disk diffusion. Carbapenemases were detected by immunochromatography. ATM and ATM-AVI MICs were determined using broth microdilution panels with avibactam fixed at 4 µg/mL. The non-susceptible isolates to ATM-AVI and those with double production of carbapenemases underwent whole-genome sequencing. A total of 438 Enterobacterales isolates were analyzed; carbapenemase production was detected in 422 (96.3%) and NDM was the most frequent (61.9%). Coproduction of NDM + KPC in K. pneumoniae and NDM + OXA-48-like in Escherichia coli was observed. Overall, 99.3% were susceptible to ATM-AVI; MIC 50 and MIC 90 were 0.12 and 2 µg/mL, respectively. Overall, K. pneumoniae isolates had lower MIC 50 and MIC 90 values to ATM-AVI (0.12 and 0.5 µg/mL) compared to E. coli (0.5 and 4 µg/mL). Three E. coli isolates were resistant to ATM-AVI (MIC ≥ 8 µg/mL), they belonged to ST410, ST167, and ST10 and harbored a YRIN insertion in PBP3 along with CYM-type, PER-type, and CTX-M-type beta-lactamase genes. ATM-AVI demonstrated potent activity against carbapenem-non-susceptible Enterobacterales , including those producing NDM, which is the carbapenemase most frequently detected in Peruvian hospitals. IMPORTANCE: Enterobacterales isolates cause common illnesses in humans. Carbapenems are the antibiotics used to treat several of these infections, and increasingly, isolates resistant to these antibiotics are found. The most important mechanism of resistance to carbapenem among Enterobacterales is the production of enzymes called carbapenemases. Our results allowed us to recognize that NDM is the most frequent type of carbapenemase detected. Most of the antimicrobials available do not cover the E nterobacterales carrying NDM carbapenemase. In this scenario, we found that the new combination of drugs, aztreonam-avibactam, has high in vitro efficacy against most of the carbapenem-resistant isolates and against those isolates carrying NDM carbapenemase.
- 1 September 2026
- Published by American Society for Microbiology in Microbiology Spectrum
- Vol. 14 (9)
Open AccessIn vitro susceptibility testing of aztreonam-avibactam against predominantly NDM-producing Enterobacterales in Peru
Metallo-β-lactamase-producing Enterobacterales are distributed worldwide, but some Latin American countries show a higher prevalence. Aztreonam-avibactam (ATM-AVI) may be an option for treating these infections. To evaluate in vitro susceptibility to aztreonam (ATM) alone and ATM-AVI in carbapenem-non-susceptible Enterobacterales isolates, based on the type of carbapenemase production, we prospectively collected carbapenem-non-susceptible Enterobacterales isolates from Peruvian hospitals during 2023–2024. Identification and susceptibility testing were performed by commercial panels and disk diffusion. Carbapenemases were detected by immunochromatography. ATM and ATM-AVI MICs were determined using broth microdilution panels with avibactam fixed at 4 µg/mL. The non-susceptible isolates to ATM-AVI and those with double production of carbapenemases underwent whole-genome sequencing. A total of 438 Enterobacterales isolates were analyzed; carbapenemase production was detected in 422 (96.3%) and NDM was the most frequent (61.9%). Coproduction of NDM + KPC in K. pneumoniae and NDM + OXA-48-like in Escherichia coli was observed. Overall, 99.3% were susceptible to ATM-AVI; MIC 50 and MIC 90 were 0.12 and 2 µg/mL, respectively. Overall, K. pneumoniae isolates had lower MIC 50 and MIC 90 values to ATM-AVI (0.12 and 0.5 µg/mL) compared to E. coli (0.5 and 4 µg/mL). Three E. coli isolates were resistant to ATM-AVI (MIC ≥ 8 µg/mL), they belonged to ST410, ST167, and ST10 and harbored a YRIN insertion in PBP3 along with CYM-type, PER-type, and CTX-M-type beta-lactamase genes. ATM-AVI demonstrated potent activity against carbapenem-non-susceptible Enterobacterales , including those producing NDM, which is the carbapenemase most frequently detected in Peruvian hospitals. IMPORTANCE: Enterobacterales isolates cause common illnesses in humans. Carbapenems are the antibiotics used to treat several of these infections, and increasingly, isolates resistant to these antibiotics are found. The most important mechanism of resistance to carbapenem among Enterobacterales is the production of enzymes called carbapenemases. Our results allowed us to recognize that NDM is the most frequent type of carbapenemase detected. Most of the antimicrobials available do not cover the E nterobacterales carrying NDM carbapenemase. In this scenario, we found that the new combination of drugs, aztreonam-avibactam, has high in vitro efficacy against most of the carbapenem-resistant isolates and against those isolates carrying NDM carbapenemase.
- Open Access
- 30 June 2026
- Published by Universidad Peruana Cayetano Heredia in Acta Herediana
- Vol. 69 (1) , 85-90
RETAMA: Programa de entrenamiento en ética en investigación
- 30 June 2026
- Published by Universidad Peruana Cayetano Heredia in Acta Herediana
- Vol. 69 (1) , 85-90
Open AccessRETAMA: Programa de entrenamiento en ética en investigación
- Open Access
- 31 March 2026
- Published by Universidad Peruana Cayetano Heredia in Revista Médica Herediana
- Vol. 37 (1) , 68-78
Rol de los actores clave para el proceso óptimo de hemocultivo: desde el médico hasta el laboratorio de microbiología
El hemocultivo es una herramienta fundamental para el diagnóstico de las infecciones del torrente sanguíneo. En este artículo se evalúan los aspectos del proceso de hemocultivos haciendo énfasis en el rol crítico que cumplen los trabajadores de la salud involucrados, incluyendo: el médico, quien debe conocer cuáles son las indicaciones; el flebotomista —que en los hospitales puede ser desempeñado por diferentes grupos incluyendo técnicos, médicos o enfermeras—, quien deben realizar el proceso utilizando una técnica aséptica; y el personal del laboratorio de microbiología, que debe seguir los procesos adecuados para obtener el resultado microbiológico. Adicionalmente, se revisa el rol del laboratorio de microbiología para evaluar y monitorear los indicadores de calidad de los hemocultivos, como son el volumen de sangre por botella, el porcentaje de positividad y el porcentaje de contaminantes, con el objetivo de optimizar el uso de esta herramienta diagnóstica.
- 31 March 2026
- Published by Universidad Peruana Cayetano Heredia in Revista Médica Herediana
- Vol. 37 (1) , 68-78
Open AccessRol de los actores clave para el proceso óptimo de hemocultivo: desde el médico hasta el laboratorio de microbiología
El hemocultivo es una herramienta fundamental para el diagnóstico de las infecciones del torrente sanguíneo. En este artículo se evalúan los aspectos del proceso de hemocultivos haciendo énfasis en el rol crítico que cumplen los trabajadores de la salud involucrados, incluyendo: el médico, quien debe conocer cuáles son las indicaciones; el flebotomista —que en los hospitales puede ser desempeñado por diferentes grupos incluyendo técnicos, médicos o enfermeras—, quien deben realizar el proceso utilizando una técnica aséptica; y el personal del laboratorio de microbiología, que debe seguir los procesos adecuados para obtener el resultado microbiológico. Adicionalmente, se revisa el rol del laboratorio de microbiología para evaluar y monitorear los indicadores de calidad de los hemocultivos, como son el volumen de sangre por botella, el porcentaje de positividad y el porcentaje de contaminantes, con el objetivo de optimizar el uso de esta herramienta diagnóstica.
- Open Access
- 25 March 2026
- Published by Elsevier in SSRN Electronic Journal
High prevalence of intestinal colonization by beta-lactam resistant Enterobacterales in patients admitted to an emergency department in Lima, Peru
Objectives: To determine the prevalence of intestinal colonization by extended-spectrum beta-lactamase-producing Enterobacterales (ESBL-E) and carbapenem resistant Enterobacterales (CRE) among patients admitted to the emergency department of a tertiary care hospital in Lima, Peru. Factors associated with colonization were also evaluated.Methods: A cross-sectional study was conducted from December 2019 to March 2020. Patients were enrolled on one to two randomly selected days per week. A rectal or fecal swab was collected, and a standardized questionnaire was administered. Samples were cultured in chromogenic media (ChromAgar ESBL and ChromAgar mSuperCarba) and disc diffusion methods were used for confirmation of ESBL production and carbapenem resistance . The association of epidemiological and clinical factors with ESBL-E and CRE colonization was analyzed using bivariate generalized linear models with a Poisson distribution and robust variance.Results: 148 patients were sampled. Prevalence of ESBL-E and CRE colonization was 73.6% (109/148) and 8.1% (12/148), respectively. Hospitalization during the previous year (PR = 1.23, 95% CI: 1.02–1.49) was associated with ESBL-E colonization.Conclusions: A high prevalence of ESBL-E intestinal colonization and ongoing undetected CRE colonization were found among patients with and without prior healthcare exposure admitted to an emergency department of a tertiary care hospital in Lima.
- 25 March 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessHigh prevalence of intestinal colonization by beta-lactam resistant Enterobacterales in patients admitted to an emergency department in Lima, Peru
Objectives: To determine the prevalence of intestinal colonization by extended-spectrum beta-lactamase-producing Enterobacterales (ESBL-E) and carbapenem resistant Enterobacterales (CRE) among patients admitted to the emergency department of a tertiary care hospital in Lima, Peru. Factors associated with colonization were also evaluated.Methods: A cross-sectional study was conducted from December 2019 to March 2020. Patients were enrolled on one to two randomly selected days per week. A rectal or fecal swab was collected, and a standardized questionnaire was administered. Samples were cultured in chromogenic media (ChromAgar ESBL and ChromAgar mSuperCarba) and disc diffusion methods were used for confirmation of ESBL production and carbapenem resistance . The association of epidemiological and clinical factors with ESBL-E and CRE colonization was analyzed using bivariate generalized linear models with a Poisson distribution and robust variance.Results: 148 patients were sampled. Prevalence of ESBL-E and CRE colonization was 73.6% (109/148) and 8.1% (12/148), respectively. Hospitalization during the previous year (PR = 1.23, 95% CI: 1.02–1.49) was associated with ESBL-E colonization.Conclusions: A high prevalence of ESBL-E intestinal colonization and ongoing undetected CRE colonization were found among patients with and without prior healthcare exposure admitted to an emergency department of a tertiary care hospital in Lima.
- Open Access
- 30 June 2025
- Published by Universidad Peruana Cayetano Heredia in Acta Herediana
- Vol. 68 (1) , 125-127
Apertura del año académico 2025: Universidad Peruana Cayetano Heredia
- 30 June 2025
- Published by Universidad Peruana Cayetano Heredia in Acta Herediana
- Vol. 68 (1) , 125-127
Open AccessApertura del año académico 2025: Universidad Peruana Cayetano Heredia
- Open Access
- 30 June 2025
- Published by Universidad Peruana Cayetano Heredia in Revista Médica Herediana
- Vol. 36 (2) , 130-135
Candidemia and antifungal susceptibility in Peruvian hospitals
Worldwide, Candida bloodstream infections have presented an increase in non-albicans Candida species and resistance to antifungal agents. Objective: To describe the microbiological characteristics of consecutive Candida blood culture isolates. Methods: This study analyzed 73 consecutive Candida blood isolates recovered between July 2017 and July 2019 from routine patient care at 15 Peruvian hospitals, assessing susceptibility to four antifungal agents. Results: The species most frequently detected were Candida parapsilosis 39 (53.4%), Candida albicans 23 (31.5%), and Candida tropicalis 5 (6.8%). Conclusions: All isolates were susceptible to amphotericin B, fluconazole, voriconazole, and anidulafungin. There is a predominance of non-albicans Candida cases in Peru and a high susceptibility to current antifungal drugs.
- 30 June 2025
- Published by Universidad Peruana Cayetano Heredia in Revista Médica Herediana
- Vol. 36 (2) , 130-135
Open AccessCandidemia and antifungal susceptibility in Peruvian hospitals
Worldwide, Candida bloodstream infections have presented an increase in non-albicans Candida species and resistance to antifungal agents. Objective: To describe the microbiological characteristics of consecutive Candida blood culture isolates. Methods: This study analyzed 73 consecutive Candida blood isolates recovered between July 2017 and July 2019 from routine patient care at 15 Peruvian hospitals, assessing susceptibility to four antifungal agents. Results: The species most frequently detected were Candida parapsilosis 39 (53.4%), Candida albicans 23 (31.5%), and Candida tropicalis 5 (6.8%). Conclusions: All isolates were susceptible to amphotericin B, fluconazole, voriconazole, and anidulafungin. There is a predominance of non-albicans Candida cases in Peru and a high susceptibility to current antifungal drugs.
- Open Access
The Association Between the Ct Value of SARS-CoV-2 and the Risk of Death from COVID-19 in Amazonas, Peru, During the Circulation of the Lambda, Gamma, and Delta Variants
This study aimed to assess the association between the cycle threshold (Ct) values of SARS-CoV-2 and the risk of death from COVID-19 in adult patients from the Amazonas region of Peru during the circulation of the Lambda, Gamma, and Delta variants. The study population included both hospitalized and outpatient patients, symptomatic and asymptomatic, between August 2020 and August 2021. The standardized Ct values of the ORF1ab gene were categorized into low and high Ct groups based on the median Ct value (28.4). Mortality data within 60 days were obtained from the Peruvian epidemiological surveillance system (Notiweb). The risk of death was estimated using Cox regression, adjusting for relevant predictors and potential confounding variables. Among symptomatic COVID-19 patients, no significant difference in the risk of death was observed between those with low and high Ct values (adjusted hazard ratio [aHR] = 1.61; 95% confidence interval [CI], 0.97–2.67; p = 0.067). However, hospitalized patients with low Ct values had a significantly higher risk of death compared to those with high Ct values (aHR = 1.82; 95% CI, 1.06–3.12; p = 0.030). This association persisted after adjusting for age, sex, occupational group, symptom duration, comorbidities, and epidemic dynamics. In conclusion, while Ct values in symptomatic COVID-19 patients (both hospitalized and outpatient) are not associated with a 60-day mortality risk, a low Ct value is linked to an increased risk of death in hospitalized patients.
Open AccessThe Association Between the Ct Value of SARS-CoV-2 and the Risk of Death from COVID-19 in Amazonas, Peru, During the Circulation of the Lambda, Gamma, and Delta Variants
This study aimed to assess the association between the cycle threshold (Ct) values of SARS-CoV-2 and the risk of death from COVID-19 in adult patients from the Amazonas region of Peru during the circulation of the Lambda, Gamma, and Delta variants. The study population included both hospitalized and outpatient patients, symptomatic and asymptomatic, between August 2020 and August 2021. The standardized Ct values of the ORF1ab gene were categorized into low and high Ct groups based on the median Ct value (28.4). Mortality data within 60 days were obtained from the Peruvian epidemiological surveillance system (Notiweb). The risk of death was estimated using Cox regression, adjusting for relevant predictors and potential confounding variables. Among symptomatic COVID-19 patients, no significant difference in the risk of death was observed between those with low and high Ct values (adjusted hazard ratio [aHR] = 1.61; 95% confidence interval [CI], 0.97–2.67; p = 0.067). However, hospitalized patients with low Ct values had a significantly higher risk of death compared to those with high Ct values (aHR = 1.82; 95% CI, 1.06–3.12; p = 0.030). This association persisted after adjusting for age, sex, occupational group, symptom duration, comorbidities, and epidemic dynamics. In conclusion, while Ct values in symptomatic COVID-19 patients (both hospitalized and outpatient) are not associated with a 60-day mortality risk, a low Ct value is linked to an increased risk of death in hospitalized patients.
- Open Access
- 4 February 2025
- Published by American Society for Microbiology in Microbiology Spectrum
- Vol. 13 (2) , e0182524
Emerging carbapenem-resistant Klebsiella pneumoniae in a tertiary care hospital in Lima, Peru
The emergence of carbapenem-resistant Klebsiella pneumoniae (CRKP) poses a significant public health threat, particularly in low- and middle-income countries (LMICs) with limited surveillance and treatment options. This study examines the genetic diversity, resistance patterns, and transmission dynamics of 66 CRKP isolates recovered over 5 years (2015–2019) after the first case of CRKP was identified at a tertiary care hospital in Lima, Peru. Our findings reveal a shift from bla KPC-2 to bla NDM-1 as the dominant carbapenemase gene after 2017. Lineage ST45 was the most prevalent and persisted for multiple years, followed by high-risk clones ST11 and ST147. The bla NDM-1 gene was carried almost exclusively by a Tn125-like transposon, similar to the one reported in previous studies from two Peruvian hospitals. Long-read sequencing revealed nearly identical bla NDM -carrying plasmids across the four assessed lineages. A comparative analysis of 1,023 South American CRKP genomes confirmed a unique pattern in Peru, where bla NDM-1 (81.4%) outpaced bla KPC-2 , which remained dominant (59.4%) elsewhere. In addition, emerging clones ST45 and ST348 found in Peru were rarely found elsewhere in South America, suggesting potential regional adaptation. In conclusion, our study provides a comprehensive picture of the intra-hospital dynamics of these emerging pathogens and provides a framework for studying their genomic diversity in the understudied South American region. IMPORTANCE: This study provides novel insights into the transmission and genetic diversity of carbapenem-resistant Klebsiella pneumoniae , a bacteria responsible for severe infections, with limited treatment options. By examining isolates recovered over 5 years at a major hospital in Lima, Peru, we demonstrated a shift from one type of resistance gene, bla KPC , to another, bla NDM , which is more challenging to treat. Our findings reveal that specific bacterial lineages carrying the bla NDM gene in a specific plasmid are emerging in Peru, including well-known high-risk strains and others rarely found elsewhere in South America. This pattern highlights an urgent need for targeted surveillance and infection control as these strains pose a significant challenge to healthcare systems. Our study provides crucial data on Klebsiella pneumoniae in Peru, contributing to broader efforts to monitor and control antibiotic-resistant infections in South America and globally.
- 4 February 2025
- Published by American Society for Microbiology in Microbiology Spectrum
- Vol. 13 (2) , e0182524
Open AccessEmerging carbapenem-resistant Klebsiella pneumoniae in a tertiary care hospital in Lima, Peru
The emergence of carbapenem-resistant Klebsiella pneumoniae (CRKP) poses a significant public health threat, particularly in low- and middle-income countries (LMICs) with limited surveillance and treatment options. This study examines the genetic diversity, resistance patterns, and transmission dynamics of 66 CRKP isolates recovered over 5 years (2015–2019) after the first case of CRKP was identified at a tertiary care hospital in Lima, Peru. Our findings reveal a shift from bla KPC-2 to bla NDM-1 as the dominant carbapenemase gene after 2017. Lineage ST45 was the most prevalent and persisted for multiple years, followed by high-risk clones ST11 and ST147. The bla NDM-1 gene was carried almost exclusively by a Tn125-like transposon, similar to the one reported in previous studies from two Peruvian hospitals. Long-read sequencing revealed nearly identical bla NDM -carrying plasmids across the four assessed lineages. A comparative analysis of 1,023 South American CRKP genomes confirmed a unique pattern in Peru, where bla NDM-1 (81.4%) outpaced bla KPC-2 , which remained dominant (59.4%) elsewhere. In addition, emerging clones ST45 and ST348 found in Peru were rarely found elsewhere in South America, suggesting potential regional adaptation. In conclusion, our study provides a comprehensive picture of the intra-hospital dynamics of these emerging pathogens and provides a framework for studying their genomic diversity in the understudied South American region. IMPORTANCE: This study provides novel insights into the transmission and genetic diversity of carbapenem-resistant Klebsiella pneumoniae , a bacteria responsible for severe infections, with limited treatment options. By examining isolates recovered over 5 years at a major hospital in Lima, Peru, we demonstrated a shift from one type of resistance gene, bla KPC , to another, bla NDM , which is more challenging to treat. Our findings reveal that specific bacterial lineages carrying the bla NDM gene in a specific plasmid are emerging in Peru, including well-known high-risk strains and others rarely found elsewhere in South America. This pattern highlights an urgent need for targeted surveillance and infection control as these strains pose a significant challenge to healthcare systems. Our study provides crucial data on Klebsiella pneumoniae in Peru, contributing to broader efforts to monitor and control antibiotic-resistant infections in South America and globally.
- Open Access
- 21 June 2024
- Published by Instituto Nacional de Salud (Peru) in Revista Peruana de Medicina Experimental Y Salud Pública
- Vol. 41 (2) , 223-4
Detección del gen MCR-1 en bacteriemias causadas por Escherichia coli y Klebsiella pneumoniae
- 21 June 2024
- Published by Instituto Nacional de Salud (Peru) in Revista Peruana de Medicina Experimental Y Salud Pública
- Vol. 41 (2) , 223-4
Open AccessDetección del gen MCR-1 en bacteriemias causadas por Escherichia coli y Klebsiella pneumoniae
- 1 November 2023
- Published by American Society of Tropical Medicine and Hygiene in The American Journal of Tropical Medicine and Hygiene
- Vol. 109 (5) , 1118-1121
Methicillin-Resistant Staphylococcus aureus Bloodstream Infections in Hospitalized Patients in Peru
: There is a knowledge gap in the epidemiology of methicillin-resistant Staphylococcus aureus (MRSA) causing bloodstream infections (BSIs) in Peru. Through a surveillance study in 13 hospitals of 10 Peruvian regions (2017–2019), we assessed the proportion of MRSA among S. aureus BSIs as well as the molecular typing of the isolates. A total of 166 S. aureus isolates were collected, and 36.1% of them were MRSA. Of note, MRSA isolates with phenotypic and genetic characteristics of the hospital-associated Chilean-Cordobes clone (multidrug-resistant SCCmec I, non–Panton-Valentine leukocidin [PVL] producers) were most commonly found (70%), five isolates with genetic characteristics of community-associated MRSA (CA-MRSA)—SCCmec IV, PVL-producer—(8.3%) were seen in three separate regions. These results demonstrate that hospital-associated MRSA is the most frequent MRSA found in patients with BSIs in Peru. They also show the emergence of S. aureus with genetic characteristics of CA-MRSA. Further studies are needed to evaluate the extension of CA-MRSA dissemination in Peru.
- 1 November 2023
- Published by American Society of Tropical Medicine and Hygiene in The American Journal of Tropical Medicine and Hygiene
- Vol. 109 (5) , 1118-1121
Methicillin-Resistant Staphylococcus aureus Bloodstream Infections in Hospitalized Patients in Peru
: There is a knowledge gap in the epidemiology of methicillin-resistant Staphylococcus aureus (MRSA) causing bloodstream infections (BSIs) in Peru. Through a surveillance study in 13 hospitals of 10 Peruvian regions (2017–2019), we assessed the proportion of MRSA among S. aureus BSIs as well as the molecular typing of the isolates. A total of 166 S. aureus isolates were collected, and 36.1% of them were MRSA. Of note, MRSA isolates with phenotypic and genetic characteristics of the hospital-associated Chilean-Cordobes clone (multidrug-resistant SCCmec I, non–Panton-Valentine leukocidin [PVL] producers) were most commonly found (70%), five isolates with genetic characteristics of community-associated MRSA (CA-MRSA)—SCCmec IV, PVL-producer—(8.3%) were seen in three separate regions. These results demonstrate that hospital-associated MRSA is the most frequent MRSA found in patients with BSIs in Peru. They also show the emergence of S. aureus with genetic characteristics of CA-MRSA. Further studies are needed to evaluate the extension of CA-MRSA dissemination in Peru.